Month: March 2021

Cancer Genetics and StemoniX Announce Merger Closing

Written by Customer Service on March 31, 2021. Posted in Public Companies.

Cancer Genetics, Inc. Renamed to Vyant Bio, Inc. Vyant Bio, Inc. will begin trading on Nasdaq under the symbol VYNT CHERRY HILL, N.J., March 31, 2021 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (the “Company” or “CGI”) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, and StemoniX, Inc. (“StemoniX”), a company empowering the discovery of new medicines through the convergence of novel human biology and software technologies, today announced their recently approved transaction has closed, and in connection with the merger, Cancer Genetics, Inc. was renamed Vyant Bio, Inc. (“Vyant Bio”) effective March 30, 2021. StemoniX will operate as a wholly-owned subsidiary of the Company. Vyant Bio will be traded on the Nasdaq under the symbol VYNT beginning on March 31, 2021. The name and ticker change will align the Company’s...

Almaden Appoints Kevin O’Kane and Alfredo Phillips to its Board of Directors

Written by Customer Service on March 31, 2021. Posted in Public Companies.

VANCOUVER, British Columbia, March 31, 2021 (GLOBE NEWSWIRE) — Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; NYSE American: AAU), is pleased to announce that it has appointed Kevin O’Kane and Alfredo Phillips as independent non-executive members of the Board of Directors, effective immediately. Kevin O’Kane is based in Vancouver and is a registered professional engineer with nearly 40 years of experience in the global mining industry. He has held executive positions with BHP in South America, including Project Director, Vice President of Health, Safety and Environment, and Asset President. Most recently, Mr. O’Kane held the position of Executive Vice-President and Chief Operating Officer for SSR Mining Inc. He holds the ESG Competent Boards Certificate and Global Competent Boards Designation (GCB.D), achieved in 2021....

Breakthrough on COVID-19 Vaccine Acknowledged by Global WholeHealth Partners, Corp. (OTC:GWHP) as AstraZeneca Aims to File Application With FDA While Dr. Anthony Fauci Says, “This is Very Likely a Very Good Vaccine”

Written by Customer Service on March 31, 2021. Posted in Public Companies.

San Clemente, CA, March 31, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Global WholeHealth Partners Corp (OTC:GWHP) offers one of the largest lines of tests for CoViD19 SARS2, and is prepared to help in the fight against CoViD19 SARS2. With the vaccine roll-out in progress, continued testing for COVID-19 is imperative and needs to remain a top priority to stop the spread of this deadly virus. Breakthrough on COVID-19 Vaccine Acknowledged by Global WholeHealth Partners, Corp (OTC:GWHP) as AstraZeneca aims to file an application with the FDA while Dr. Anthony Fauci says, “This is very likely a very good vaccine.” Charles Strongo, CEO of Global WholeHealth Partners, Corp., said, “We were very encouraged by the AstraZeneca report that highlighted the effectiveness of their vaccine.” Strongo also mentioned that...

Affimed and NKMax America Announce FDA Clearance of IND Application to Study the Combination of AFM24, an EGFR Targeted Innate Cell Engager, with SNK-01 Natural Killer Cell Therapy in Solid Tumors

Written by Customer Service on March 31, 2021. Posted in Public Companies.

Heidelberg, Germany and Santa Ana, Calif., March 31, 2021 – Affimed N.V. (NASDAQ: AFMD), a clinical-stage immuno-oncology company, and NKMax America Inc., a clinical stage biotech company, announced today that the U.S. Food and Drug Administration (FDA) cleared an investigational new drug application (IND) for an Affimed and NKMax America co-sponsored Phase 1/2a dose escalation and expansion study in which the two companies will investigate the combination of AFM24, an EGFR/CD16A innate cell engager (ICE®), and SNK-01, an autologous NK-cell product, in patients suffering from tumors known to express EGFR. The combination represents a novel approach to exploring innate immunity-based therapeutics to treat patients with solid tumors who failed conventional therapy with the aim to improve outcomes for high-medical need patient populations. “This...

AB “Linas” the Ordinary General Meeting of Shareholders convocation

Written by Customer Service on March 31, 2021. Posted in Public Companies.

Ordinary General Meeting of Shareholders of AB “Linas” (company code 147689083, address S. Kerbedzio str.23, Panevezys) will be held on April 30, 2021 acc. to the decision and initiative of the Board. Date of the meeting – April 30, 2021, Friday. Time of the meeting – 13:00 a.m. Registration of participants from 12:00 a.m. till 12:45 a.m. Place of the meeting – AB “Linas” premises, S. Kerbedzio str. 23, Panevezys. Taking into account that the quarantine announced in the territory of the Republic of Lithuania by Government Resolution No. 1226 of 4 November 2020 includes the day of the Shareholders Meeting Day, the management of the Company strongly urges the Company’s shareholders to vote on the agenda items in writing, by filling voting ballot. Agenda of the meeting:The conclusion of the auditor about consolidated and Company’s...

AB „Linas“ eilinio visuotinio akcininkų susirinkimo sušaukimas

Written by Customer Service on March 31, 2021. Posted in Public Companies.

AB „Linas“, juridinio asmens kodas 147689083, buveinės adresas S. Kerbedžio g. 23, Panevėžys, valdybos iniciatyva ir sprendimu 2021 m. balandžio 30 d. šaukiamas AB „Linas“ eilinis visuotinis akcininkų susirinkimas. Susirinkimo data – 2021 m. balandžio 30 d., penktadienis. Susirinkimo laikas – 13.00 valanda. Registracija vyks nuo 12 val. iki 12.45 val. Susirinkimo vieta – AB „Linas“ buveinės salėje, S.Kerbedžio g. 23, Panevėžyje. Atsižvelgiant į tai, kad 2020 m. lapkričio 4 d. Lietuvos Respublikos Vyriausybės nutarimu Nr. 1226 Lietuvos Respublikos teritorijoje paskelbto karantino galiojimas pratęstas ir apima susirinkimo dieną – primygtinai kviečiame Bendrovės akcininkus pasinaudoti teise balsuoti Susirinkimo dienotvarkės klausimais pateikiant Bendrovei tinkamai užpildytus bendruosius balsavimo biuletenius. Susirinkimo darbotvarkė:Auditoriaus...

Rättelse: Kallelse till årsstämma i TerraNet Holding AB

Written by Customer Service on March 31, 2021. Posted in Public Companies.

Det ver felaktigt med en MAR-etikett i det pressmeddelande som publicerades tidigare idag.

Correction: Notice of annual general meeting in TerraNet Holding

Written by Customer Service on March 31, 2021. Posted in Public Companies.

The MAR label was not applicable in the press release published earlier today.

Cooling Towers Market worth USD 4.63 Billion at 3.7% CAGR; SPIG S.p.A. Finishes Upgradation of TEMCO’s Production Facility, says Fortune Business Insights™

Written by Customer Service on March 31, 2021. Posted in Mergers And Acquisitions.

Pune, India, March 31, 2021 (GLOBE NEWSWIRE) — The cooling towers market is set to gain impetus from the rising inclination of people towards eco-friendly products. This information is given by Fortune Business Insights™ in a new report, titled, “Cooling Towers Market, 2020-2027.” The report further states that the cooling towers market size was USD 3.50 billion in 2019. It is set to reach USD 4.63 billion in 2027 at a CAGR of 3.7% during the forecast period. Governments of various countries are transforming their initiatives to encourage the development of sustainable products. NSW Public Health Regulation 2012, for instance, published new rules to prevent the growth and transmission of the Legionella bacteria. Request To Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cooling-towers-market-102747 COVID-19...

Tulikivi Corporation’s Annual Report for 2020 Has Been Published

Written by Customer Service on March 31, 2021. Posted in Public Companies.

31 March 2021 at 1 pm TULIKIVI CORPORATIONANNUAL REPORT 31 MARCH 2021 AT 1 PM TULIKIVI CORPORATION’S ANNUAL REPORT FOR 2020 HAS BEEN PUBLISHEDThe Annual Report for 2020 includes the company’s financial statements for 2020 and the auditors’ report, the Board of Directors’ report, the corporate governance statement and the remuneration report. The annual report is attached to this release as a PDF file and available on the company’s website www.tulikivi.com. TULIKIVI CORPORATIONBoard of DirectorsFurther information: Heikki Vauhkonen, Managing Director, tel. +358 (0)207 636 555Distribution: Nasdaq HelsinkiKey mediawww.tulikivi.com AttachmentTK_VK_2020_ENG

Month: March 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals